Robert H. Belmaker
Ben-Gurion University of the Negev
438 Papers
6.2K Citations
Robert H. Belmaker is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Lithium (medication) & Inositol. The author has an hindex of 65, co-authored 436 publications. Previous affiliations of Robert H. Belmaker include National Institutes of Health & Israel Institute for Biological Research.
Chat about Author
Papers
Major depressive disorder.
Robert H. Belmaker,Galila Agam +1 more
TL;DR: This review presents the major current approaches to understanding the biologic mechanisms of major depression and defines depression as a heterogeneous disorder with a highly variable course, an inconsistent response to treatment, and no established mechanism.
Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder
TL;DR: It is not possible to distinguish whether E-EPA augments antidepressant action in the manner of lithium or has independent antidepressant properties of its own.
681
Omega-3 treatment of childhood depression: a controlled, double-blind pilot study.
TL;DR: Omega-3 fatty acids may have therapeutic benefits in childhood depression and analysis of variance showed highly significant effects of omega-3 on symptoms using the CDRS, CDI, and CGI.
Double-blind, controlled trial of inositol treatment of depression.
TL;DR: This may be the first use of the precursor strategy for a second messenger rather than a neurotransmitter in treating depression, and inositol had a significant antidepressant effect in this study.
244
Transcranial Magnetic Stimulation in Mania: A Controlled Study
TL;DR: The therapeutic effect of transcranial magnetic stimulation in mania may show laterality opposite to its effect in depression.
216